Agnese Secondo Selected Research

Agnese Secondo Research Topics

Disease

8	Brain Ischemia (Cerebral Ischemia) 10/2020 - 01/2008
7	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2022 - 09/2014
6	Stroke (Strokes) 01/2022 - 01/2013
6	Hypoxia (Hypoxemia) 01/2020 - 03/2007
5	Alzheimer Disease (Alzheimer's Disease) 01/2022 - 08/2012
5	Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome) 01/2019 - 11/2009
5	Infarction (Infarctions) 08/2015 - 03/2004
5	Neuroblastoma 01/2015 - 11/2004
4	Neoplasms (Cancer) 01/2018 - 12/2011
3	Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease) 12/2022 - 10/2019
2	Dementia (Dementias) 12/2022 - 01/2019
2	Nervous System Diseases (Neurological Disorders) 01/2020 - 04/2003
2	Down Syndrome (Down's Syndrome) 01/2020 - 01/2019
2	Inflammation (Inflammations) 01/2019 - 04/2016
2	Celiac Disease (Celiac Sprue) 01/2013 - 01/2012
1	Neuroinflammatory Diseases 01/2022
1	Insulin Resistance 01/2022
1	Central Nervous System Diseases (CNS Diseases) 01/2021
1	Spinal Muscular Atrophy (Progressive Muscular Atrophy) 01/2020
1	Multiple Sclerosis 01/2020
1	Autosomal Dominant Optic Atrophy (Dominant Optic Atrophy) 01/2019
1	Demyelinating Diseases (Demyelinating Disease) 01/2019
1	Schizophrenia (Dementia Praecox) 01/2019
1	Gliosis 12/2018
1	Prostatic Neoplasms (Prostate Cancer) 01/2018
1	Prostatic Hyperplasia (Benign Prostatic Hyperplasia) 01/2018
1	Vascular Remodeling 04/2016
1	Lung Neoplasms (Lung Cancer) 04/2016
1	Mitochondrial Diseases (Mitochondrial Disease) 01/2015
1	Lymphatic Metastasis 03/2014
1	Thyroid Neoplasms (Thyroid Cancer) 03/2014
1	medullary Thyroid cancer 03/2014
1	Memory Disorders (Memory Loss) 01/2013
1	Colorectal Neoplasms (Colorectal Cancer) 12/2011

Drug/Important Bio-Agent (IBA)

10	CalciumIBA 01/2022 - 11/2004
8	Protein Isoforms (Isoforms)IBA 01/2020 - 03/2007
5	Proteins (Proteins, Gene)FDA Link 01/2019 - 02/2003
5	Sodium-Calcium ExchangerIBA 03/2016 - 03/2009
3	Glucose (Dextrose)FDA LinkGeneric 01/2019 - 02/2013
3	Oxygen (Dioxygen)IBA 01/2019 - 02/2013
3	Chlorodiphenyl (54% Chlorine)IBA 01/2015 - 08/2006
3	Polychlorinated Biphenyls (PCBs)IBA 01/2015 - 08/2006
3	Adenosine Triphosphate (ATP)IBA 12/2007 - 05/2005
2	beta-N-methylamino-L-alanine (beta-methylamino-L-alanine)IBA 12/2022 - 01/2019
2	PolyphenolsIBA 01/2022 - 11/2015
2	Peptides (Polypeptides)IBA 01/2022 - 08/2012
2	Neuroprotective AgentsIBA 01/2022 - 01/2013
2	IonsIBA 01/2021 - 02/2013
2	Pioglitazone (Actos)FDA Link 01/2020 - 01/2019
2	SodiumIBA 01/2020 - 02/2013
2	Messenger RNA (mRNA)IBA 01/2018 - 03/2014
2	sodium-calcium exchanger 1IBA 01/2013 - 11/2009
2	AntiportersIBA 01/2013 - 01/2013
2	Pharmaceutical PreparationsIBA 12/2011 - 05/2005
2	EnzymesIBA 01/2011 - 11/2004
2	Superoxide Dismutase-1IBA 01/2011 - 11/2004
2	EstersIBA 11/2009 - 05/2005
2	Fura-2 (Fura 2)IBA 11/2009 - 05/2005
1	NeurotoxinsIBA 12/2022
1	PhytochemicalsIBA 01/2022
1	Monoterpenes (Monoterpenoids)IBA 01/2022
1	Amyloid (Amyloid Fibrils)IBA 01/2022
1	Volatile Oils (Essential Oils)IBA 06/2021
1	Protective AgentsIBA 06/2021
1	Ion Channels (Ion Channel)IBA 01/2021
1	Sodium Channels (Sodium Channel)IBA 01/2021
1	AcidsIBA 01/2021
1	Dynamins (Dynamin)IBA 01/2019
1	ORAI1 ProteinIBA 01/2019
1	Cyanobacteria ToxinsIBA 01/2019
1	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 01/2019
1	D-Aspartic Acid (D Aspartate)IBA 01/2019
1	Nonesterified Fatty Acids (NEFA)IBA 01/2018
1	Oleic Acid (Oleate)IBA 01/2018
1	Biological ProductsIBA 01/2018
1	G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA 01/2018
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 04/2016
1	Cannabinoid Receptors (Cannabinoid Receptor)IBA 04/2016
1	Calcium-Binding ProteinsIBA 03/2016
1	Calbindin 2IBA 03/2016
1	Histone Deacetylases (Histone Deacetylase)IBA 11/2015
1	Sirtuin 1IBA 11/2015
1	ResveratrolIBA 11/2015
1	5- amino- N- butyl- 2- (4- ethoxyphenoxy)- benzamide hydrochlorideIBA 08/2015
1	Dihydrotachysterol (AT 10)IBA 08/2015
1	LeptinIBA 09/2014
1	N-Methylaspartate (NMDA)IBA 09/2014
1	Large-Conductance Calcium-Activated Potassium Channels (Maxi-K Channels)IBA 09/2014
1	Calcium-Calmodulin-Dependent Protein Kinase Type 2IBA 03/2014
1	Calcium-Calmodulin-Dependent Protein KinasesIBA 03/2014
1	Calcitonin (Calcitonin, Eel)FDA LinkGeneric 03/2014
1	Cyclic AMP-Dependent Protein Kinases (cAMP-Dependent Protein Kinase)IBA 12/2013
1	RE1-silencing transcription factorIBA 02/2013
1	Protein Glutamine gamma Glutamyltransferase 2IBA 01/2013
1	AntibodiesIBA 01/2013
1	7- nitro- 5- phenyl- 1- (pyrrolidin- 1- ylmethyl)- 1H- benzo(e)(1,4)diazepin- 2(3H)- oneIBA 01/2013
1	GliadinIBA 01/2012
1	Carrier Proteins (Binding Protein)IBA 12/2011

Therapy/Procedure

1	Therapeutics 10/2020
1	Denervation 12/2018